Literature DB >> 21279956

Recent advances in breast cancer metastasis suppressor 1.

Xiuping Chen1, Zengtao Xu, Yitao Wang.   

Abstract

Metastasis is a complex process divided into a number of steps including detachment of tumor cells from the primary tumor, invasion, migration, intravasation, survival in the vasculature, extravasation, and colonization of the secondary site. Proteins that block metastasis without inhibiting primary tumor formation are known as metastasis suppressors; examples are NM23, Maspin, KAI1, KISS1, and MKK4. Breast cancer metastasis suppressor 1 (BRMS1) was identified as a suppressor of breast cancer metastasis in the late 1990s. In vitro and in vivo studies have confirmed that BRMS1 is a potent metastasis suppressor not limited to breast cancer. However, conflicting clinical observations regarding its role as a metastasis suppressor and its validity as a diagnostic biomarker warrant more in-depth clinical study. In this review, the authors provide an overview of its biology, function, action mechanism and pathological significance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21279956     DOI: 10.5301/jbm.2011.6267

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   2.659


  5 in total

1.  MTBP inhibits migration and metastasis of hepatocellular carcinoma.

Authors:  Qian Bi; Atul Ranjan; Rui Fan; Neeraj Agarwal; Danny R Welch; Steven A Weinman; Jie Ding; Tomoo Iwakuma
Journal:  Clin Exp Metastasis       Date:  2015-03-11       Impact factor: 5.150

2.  Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression.

Authors:  Xiu-Jie Sheng; Ying-Qun Zhou; Qing-Yuan Song; Dong-Mei Zhou; Qi-Cai Liu
Journal:  Oncol Rep       Date:  2011-12-19       Impact factor: 3.906

3.  MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4.

Authors:  N Agarwal; A S Adhikari; S V Iyer; K Hekmatdoost; D R Welch; T Iwakuma
Journal:  Oncogene       Date:  2012-02-27       Impact factor: 9.867

4.  BRMS1 suppresses glioma progression by regulating invasion, migration and adhesion of glioma cells.

Authors:  Pengjin Mei; Jin Bai; Meilin Shi; Qinghua Liu; Zhonglin Li; Yuechao Fan; Junnian Zheng
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

5.  Down Regulation of KAI1/CD82 in Lymph Node Positive and Advanced T-Stage Group in Breast Cancer Patients.

Authors:  Thammineni Krishna Latha; Ankur Verma; Gaurav Kumar Thakur; Basudev Banerjee; Navneet Kaur; Usha Rani Singh; Sonal Sharma
Journal:  Asian Pac J Cancer Prev       Date:  2019-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.